Category Uncategorized

Brutini 140mg | Ibrutinib | Anti-Cancer

Brutini 140

Brutini 140. Generic Name: Ibrutinib Theraputic. Category: Anti-Cancer. Pack Size: 120’s. Order Now. Brutini 140 mg (Ibrutinib) [Indications] 1. Single drug is suitable for the treatment of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. As an Ibrutinib medication, it addresses the complex…

Olakin Tablet | Olaparib 150 mg

olakin-150-mg-tablet

Indications Breast Cancer: Olakin is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in…

Abeclib 150mg Tablet (Abemaciclib)

Abeclib Tablet Pack Image Abemaciclib 150 mg

Indications Abeclib is a kinase inhibitor indicated: * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন‘ Pharmacology Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive…

Rematib Tablet 15mg Upadacitinib (Extended Release)

rematib 15 mg tablet

Indications Rematib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন‘ Pharmacology…

Osikin Tablet | Osimertinib 80 mg

Indications : Osikin is indicated for the treatment of patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy. Osikin is indicated for the…

Osikin Tablet 80 mg | Osimertinib

Osikin Tablet Pack Image Osimertinib

Indications : Osikin is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test.…